SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: paul goldstein who wrote (270)7/30/1996 12:12:00 PM
From: Rick Costantino   of 4342
 
Things are pretty quiet out there for PRLN and the market in general.
However, I see several interesting events occurring over the next 1-4
months which should move the stock (some are speculative, I know):

(1) Announcement of Phase I results for PN355,1 AIDS trial

(2) Dr Babish's conference call regarding the molecular mechanism
of PN355,1 towards inhibiting AIDS replication in T-cells.

(3) A scientific paper on the above? Someone mecntioned this in a
previous post.

(4) Begin Phase II trials for PN355,1? As long as Phase I looks good,
which is likely.

(5) Announce results of large-scale compassionate-use clinical
trial for PN277,1 for various cancers. Very exciting if positive.

(6) IND filing for the above? Begin traditional Phase I trials?
This will depend on how positive (5) is.

(7) Partnership with a larger pharmaceutical company? Purely
speculation, but as PRLN gets further along it will need more $$.

If only a few of these come off positive the stock should increase.
Any comments?

Rick
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext